The 14th Annual Food and Drug Administration-Orange County Regulatory Affairs Educational Conference in Irvine, California: New Regulatory Challenges, 19373 [2011-8283]

Download as PDF 19373 Federal Register / Vol. 76, No. 67 / Thursday, April 7, 2011 / Notices TABLE 9B.—HOSPITAL RECLASSIFICATIONS AND REDESIGNATIONS BY INDIVIDUAL HOSPITAL UNDER SECTION 508 OF PUBLIC LAW 108–173—FY 2011—Continued CCN 330106 330126 330135 330205 330264 340002 390001 390003 390045 390072 390095 390119 390137 390169 390185 390192 390237 390270 430005 470003 490001 530015 Note ............................................................................................................. ............................................................................................................. ............................................................................................................. ............................................................................................................. ............................................................................................................. ............................................................................................................. ............................................................................................................. ............................................................................................................. ............................................................................................................. ............................................................................................................. ............................................................................................................. ............................................................................................................. ............................................................................................................. ............................................................................................................. ............................................................................................................. ............................................................................................................. ............................................................................................................. ............................................................................................................. ............................................................................................................. ............................................................................................................. ............................................................................................................. ............................................................................................................. Geographic CBSA ........................ ........................ ........................ ........................ ........................ ........................ ........................ ........................ ** ........................ ........................ ........................ ........................ ........................ ........................ ........................ ........................ ........................ ........................ ........................ ........................ ........................ 35004 35644 35644 35644 35004 16740 10900 10900 10900 10900 10900 10900 10900 10900 29540 10900 10900 29540 39660 14484 31340 53 Wage index CBSA section 508 reclassification Own wage index ........................ 1.2867 1.2867 1.2867 1.2529 0.9087 0.9370 0.9370 0.9370 0.9370 0.9370 0.9370 0.9370 0.9370 0.9852 0.9370 0.9370 0.9852 1.0934 1.1629 0.8514 ........................ 1.4341 ........................ ........................ ........................ ........................ ........................ ........................ ........................ ........................ ........................ ........................ ........................ ........................ ........................ ........................ ........................ ........................ ........................ ........................ ........................ ........................ 1.0577 * These hospitals are assigned a wage index value under a special exceptions policy (see FY 2005 IPPS final rule, 69 FR 49105). ** This hospital has been assigned a wage index under a special exceptions policy (see FY 2007 IPPS final rule, 71 FR 48070). [FR Doc. 2011–8209 Filed 4–6–11; 8:45 am] BILLING CODE 4120–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2011–N–0002] The 14th Annual Food and Drug Administration-Orange County Regulatory Affairs Educational Conference in Irvine, California: New Regulatory Challenges AGENCY: Food and Drug Administration, HHS. mstockstill on DSKH9S0YB1PROD with NOTICES ACTION: Notice of conference. The Food and Drug Administration (FDA) is announcing the following conference: 14th Annual Educational Conference co-sponsored with the Orange County Regulatory Affairs Discussion Group (OCRA). The conference is intended to provide the drug, device, biologics, and dietary supplement industries with an opportunity to interact with FDA reviewers and compliance officers from the centers and District Offices, as well as from other industry experts. The main focus of this interactive conference will be product approval, compliance, and risk management in the three medical product areas. Industry speakers, interactive Q & A, and VerDate Mar<15>2010 19:53 Apr 06, 2011 Jkt 223001 workshop sessions will also be included to assure open exchange and dialogue on the relevant regulatory issues. Date and Time: The conference will be held on June 8 and 9, 2011, from 7:30 a.m. to 5 p.m. Location: The conference will be held at the Irvine Marriott Hotel, 18000 Von Karman Ave., Irvine, CA 92612. Contact: Linda Hartley, Office of Regulatory Affairs, Food and Drug Administration, 19701 Fairchild, Irvine, CA 92612, Voice: 949–608–4413, Fax: 949–608–4417; or Orange County Regulatory Affairs Discussion Group, Attention to Detail, 5319 University Dr., suite 641, Irvine, CA 92612, Voice: 949– 387–9046, Fax: 949–387–9047, Web site: https://www.ocra-dg.org. (FDA has verified the Web site address, but FDA is not responsible for any subsequent changes to the Web site after this document publishes in the Federal Register.) Registration and Meeting Information: See OCRA’s Web site at https:// www.ocra-dg.org. Contact Attention to Detail at 949–387–9046. Before May 1, 2011, registrations fees are as follows: $675.00 for members, $725.00 for non-members and $475.00 for FDA/Government/Students.* After May 1, 2011, $725.00 for members, $775.00 for non-members, and $475.00 for FDA/Government/Students.* * OCRA student rate applies to those individuals enrolled in a regulatory or PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 quality-related academic program at an accredited institution. Proof of enrollment required. The registration fee will cover actual expenses including refreshments, lunch, materials, parking, and speaker expenses. If you need special accommodations due to a disability, please contact Linda Hartley (see Contact) at least 10 days in advance. Transcripts: Transcripts will not be available for the conference. Dated: April 1, 2011. Leslie Kux, Acting Assistant Commissioner for Policy. [FR Doc. 2011–8283 Filed 4–6–11; 8:45 am] BILLING CODE 4160–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2010–N–0443] Cathryn Lyn Chatman (also known as Cathryn Lyn Garcia): Debarment Order AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is issuing an order under the Federal Food, Drug, and Cosmetic Act (the FD&C Act) debarring SUMMARY: E:\FR\FM\07APN1.SGM 07APN1

Agencies

[Federal Register Volume 76, Number 67 (Thursday, April 7, 2011)]
[Notices]
[Page 19373]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-8283]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2011-N-0002]


The 14th Annual Food and Drug Administration-Orange County 
Regulatory Affairs Educational Conference in Irvine, California: New 
Regulatory Challenges

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of conference.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA) is announcing the following 
conference: 14th Annual Educational Conference co-sponsored with the 
Orange County Regulatory Affairs Discussion Group (OCRA). The 
conference is intended to provide the drug, device, biologics, and 
dietary supplement industries with an opportunity to interact with FDA 
reviewers and compliance officers from the centers and District 
Offices, as well as from other industry experts. The main focus of this 
interactive conference will be product approval, compliance, and risk 
management in the three medical product areas. Industry speakers, 
interactive Q & A, and workshop sessions will also be included to 
assure open exchange and dialogue on the relevant regulatory issues.
    Date and Time: The conference will be held on June 8 and 9, 2011, 
from 7:30 a.m. to 5 p.m.
    Location: The conference will be held at the Irvine Marriott Hotel, 
18000 Von Karman Ave., Irvine, CA 92612.
    Contact: Linda Hartley, Office of Regulatory Affairs, Food and Drug 
Administration, 19701 Fairchild, Irvine, CA 92612, Voice: 949-608-4413, 
Fax: 949-608-4417; or Orange County Regulatory Affairs Discussion 
Group, Attention to Detail, 5319 University Dr., suite 641, Irvine, CA 
92612, Voice: 949-387-9046, Fax: 949-387-9047, Web site: https://www.ocra-dg.org. (FDA has verified the Web site address, but FDA is not 
responsible for any subsequent changes to the Web site after this 
document publishes in the Federal Register.)
    Registration and Meeting Information: See OCRA's Web site at https://www.ocra-dg.org. Contact Attention to Detail at 949-387-9046.
    Before May 1, 2011, registrations fees are as follows: $675.00 for 
members, $725.00 for non-members and $475.00 for FDA/Government/
Students.* After May 1, 2011, $725.00 for members, $775.00 for non-
members, and $475.00 for FDA/Government/Students.*
    * OCRA student rate applies to those individuals enrolled in a 
regulatory or quality-related academic program at an accredited 
institution. Proof of enrollment required.
    The registration fee will cover actual expenses including 
refreshments, lunch, materials, parking, and speaker expenses.
    If you need special accommodations due to a disability, please 
contact Linda Hartley (see Contact) at least 10 days in advance.
    Transcripts: Transcripts will not be available for the conference.

    Dated: April 1, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011-8283 Filed 4-6-11; 8:45 am]
BILLING CODE 4160-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.